12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Exparel: Phase IV data

Top-line data from the open-label Phase IV IMPROVE trial in 39 patients undergoing open colectomy, laparoscopic colectomy or ileostomy reversal surgical procedures showed that an Exparel-based multi-modal regimen met all 3 co-primary endpoints vs. standard opioid-based postsurgical regimen. Specifically, the Exparel regimen led to a significant reduction...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >